Clinical Trial Update: the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and efficacy of allogeneic adipose-derived mesenchymal stem cell exosomes in Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Allogenic Adipose MSC-Exos (allogeneic adipose-derived mesenchymal stem cell exosomes)

Snippet

Sponsor: Ruijin Hospital | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: UNKNOWN